bioXXmed Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Mark-André Freyberg
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 24.7yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
CEO
Mark-André Freyberg
24.7yrs
Tenure
Dr. Mark-Andr? Freyberg co-founded bioXXmed AG (formerly known as CytoTools AG) in 2000 and serves as Chief Executive Officer since 2000 and had been the Chairman of Management Board until September 30, 20...